Cosmo N.V. (CMOPF)
Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
$76.37-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+1.8%
The outlook
Cosmo N.V. currently reads as bearish based on below its 50- & 200-day averages, 1% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Market cap
$1.31B
52-wk high
$169.90
52-wk low
$75.00
50-day avg
$86.46
200-day avg
$109.38
Trailing P/E
—